<DOC>
	<DOC>NCT01895452</DOC>
	<brief_summary>This is an extension of a previous study (ALK9072-003EXT). The purpose of this study is to continue to evaluate the long-term safety and durability of effect of ALKS 9072 in subjects with stable schizophrenia, and to allow subjects who are doing well on ALKS 9072 to continue treatment.</brief_summary>
	<brief_title>An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Completed the treatment period of Study ALK9072003EXT Continues to require chronic treatment with an antipsychotic medication Continues to reside in a stable living situation Continues to have an identified reliable informant Abnormal clinical laboratory value, vital sign, or electrocardiogram (ECG) finding during participation in Study ALK9072003EXT that was clinically relevant and related to study drug Missed more than 1 scheduled study visit during participation in the preceding Study ALK9072003EXT Has a significant or unstable medical condition that would preclude safe completion of the current study Subject is pregnant or breastfeeding Subject expects to be incarcerated, or has pending legal action which may impact compliance with study participation or procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>